These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

383 related articles for article (PubMed ID: 19947883)

  • 1. Properdin: emerging roles of a pattern-recognition molecule.
    Kemper C; Atkinson JP; Hourcade DE
    Annu Rev Immunol; 2010; 28():131-55. PubMed ID: 19947883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Properdin and complement activation: a fresh perspective.
    Hourcade DE
    Curr Drug Targets; 2008 Feb; 9(2):158-64. PubMed ID: 18288967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Properdin: New roles in pattern recognition and target clearance.
    Kemper C; Hourcade DE
    Mol Immunol; 2008 Oct; 45(16):4048-56. PubMed ID: 18692243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The complement protein properdin binds apoptotic T cells and promotes complement activation and phagocytosis.
    Kemper C; Mitchell LM; Zhang L; Hourcade DE
    Proc Natl Acad Sci U S A; 2008 Jul; 105(26):9023-8. PubMed ID: 18579773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Properdin in complement activation and tissue injury.
    Lesher AM; Nilsson B; Song WC
    Mol Immunol; 2013 Dec; 56(3):191-8. PubMed ID: 23816404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Properdin, a positive regulator of complement activation, is released from secondary granules of stimulated peripheral blood neutrophils.
    Wirthmueller U; Dewald B; Thelen M; Schäfer MK; Stover C; Whaley K; North J; Eggleton P; Reid KB; Schwaeble WJ
    J Immunol; 1997 May; 158(9):4444-51. PubMed ID: 9127010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Properdin binds to late apoptotic and necrotic cells independently of C3b and regulates alternative pathway complement activation.
    Xu W; Berger SP; Trouw LA; de Boer HC; Schlagwein N; Mutsaers C; Daha MR; van Kooten C
    J Immunol; 2008 Jun; 180(11):7613-21. PubMed ID: 18490764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insights Into Enhanced Complement Activation by Structures of Properdin and Its Complex With the C-Terminal Domain of C3b.
    van den Bos RM; Pearce NM; Granneman J; Brondijk THC; Gros P
    Front Immunol; 2019; 10():2097. PubMed ID: 31552043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Properdin can initiate complement activation by binding specific target surfaces and providing a platform for de novo convertase assembly.
    Spitzer D; Mitchell LM; Atkinson JP; Hourcade DE
    J Immunol; 2007 Aug; 179(4):2600-8. PubMed ID: 17675523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The complement system in systemic autoimmune disease.
    Chen M; Daha MR; Kallenberg CG
    J Autoimmun; 2010 May; 34(3):J276-86. PubMed ID: 20005073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune evasion by a staphylococcal complement inhibitor that acts on C3 convertases.
    Rooijakkers SH; Ruyken M; Roos A; Daha MR; Presanis JS; Sim RB; van Wamel WJ; van Kessel KP; van Strijp JA
    Nat Immunol; 2005 Sep; 6(9):920-7. PubMed ID: 16086019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recruitment of properdin by bi-specific nanobodies activates the alternative pathway of complement.
    Pedersen DV; Rösner T; Hansen AG; Andersen KR; Thiel S; Andersen GR; Valerius T; Laursen NS
    Mol Immunol; 2020 Aug; 124():200-210. PubMed ID: 32599335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Complement and its role in the process of inflammation].
    Wize J
    Acta Physiol Pol; 1983; 34 Suppl 25():1-18. PubMed ID: 6202093
    [No Abstract]   [Full Text] [Related]  

  • 14. Properdin binds independent of complement activation in an in vivo model of anti-glomerular basement membrane disease.
    O'Flynn J; Kotimaa J; Faber-Krol R; Koekkoek K; Klar-Mohamad N; Koudijs A; Schwaeble WJ; Stover C; Daha MR; van Kooten C
    Kidney Int; 2018 Dec; 94(6):1141-1150. PubMed ID: 30322716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Properdin: A multifaceted molecule involved in inflammation and diseases.
    Chen JY; Cortes C; Ferreira VP
    Mol Immunol; 2018 Oct; 102():58-72. PubMed ID: 29954621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The role of complement in autoimmune thyroid disorders].
    Potluková E; Limanová Z
    Cas Lek Cesk; 2007; 146(3):210-4. PubMed ID: 17419301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A regulatory role for complement in innate immunity and autoimmunity.
    Nauta AJ; Roos A; Daha MR
    Int Arch Allergy Immunol; 2004 Aug; 134(4):310-23. PubMed ID: 15218334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Local release of properdin in the cellular microenvironment: role in pattern recognition and amplification of the alternative pathway of complement.
    Cortes C; Ohtola JA; Saggu G; Ferreira VP
    Front Immunol; 2012; 3():412. PubMed ID: 23335922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The alternative pathway of complement in disease: opportunities for therapeutic targeting.
    Holers VM; Thurman JM
    Mol Immunol; 2004 Jun; 41(2-3):147-52. PubMed ID: 15159060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inherited complement regulatory protein deficiency predisposes to human disease in acute injury and chronic inflammatory statesthe examples of vascular damage in atypical hemolytic uremic syndrome and debris accumulation in age-related macular degeneration.
    Richards A; Kavanagh D; Atkinson JP
    Adv Immunol; 2007; 96():141-77. PubMed ID: 17981206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.